"Seit vielen Jahren leistet die Solinger St. Lukas Klinik einen wesentlichen Beitrag zur Gesundheitsversorgung in der Region. Dabei bietet das Krankenhaus überregional ausgerichtete Leistungsschwerpunkte."

During the past decade, St. Lukas - Clinic Solingen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Lukas - Clinic Solingen" are "Lymphoma" (3 trials). Many other conditions were trialed in "St. Lukas - Clinic Solingen" in a lesser frequency.

Most popular intervention types in "St. Lukas - Clinic Solingen" are "Biological" (3 trials), "Drug" (3 trials), "Radiation" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Lukas - Clinic Solingen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "St. Lukas - Clinic Solingen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in St. Lukas - Clinic Solingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Lukas - Clinic Solingen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".